First Trust Direct Indexing’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-62,877
Closed -$10.2M 473
2024
Q3
$10.2M Buy
62,877
+8,874
+16% +$1.41M 0.55% 22
2024
Q2
$7.89M Sell
54,003
-1,541
-3% -$229K 0.49% 26
2024
Q1
$8.79M Buy
55,544
+5,298
+11% +$843K 0.65% 20
2023
Q4
$7.88M Buy
50,246
+5,692
+13% +$873K 0.7% 16
2023
Q3
$6.94M Buy
44,554
+1,767
+4% +$292K 0.79% 14
2023
Q2
$7.08M Buy
42,787
+3,906
+10% +$630K 0.79% 11
2023
Q1
$6.03M Buy
38,881
+4,940
+15% +$798K 0.72% 15
2022
Q4
$6M Buy
33,941
+2,215
+7% +$382K 0.8% 12
2022
Q3
$5.18M Sell
31,726
-796
-2% -$135K 0.76% 15
2022
Q2
$5.77M Buy
32,522
+1,430
+5% +$255K 0.8% 14
2022
Q1
$5.51M Buy
31,092
+2,561
+9% +$436K 0.67% 17
2021
Q4
$4.88M Buy
28,531
+532
+2% +$87.1K 0.63% 19
2021
Q3
$4.52M Buy
27,999
+712
+3% +$121K 0.64% 18
2021
Q2
$4.5M Buy
27,287
+8,485
+45% +$1.4M 0.67% 18
2021
Q1
$3.09M Buy
18,802
+1,832
+11% +$296K 0.82% 16
2020
Q4
$2.67M Buy
+16,970
New +$2.5M 0.72% 14

Other funds holding JNJ

First Trust Direct Indexing's JNJ Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 62,877 shares — an estimated $10.2M sold.

First Trust Direct Indexing first reported a position in JNJ in Q4 2020 and held it in 16 quarters. The position peaked at $10.2M in Q3 2024. 4,104 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 62,877 Johnson & Johnson shares in Q4 2024, an estimated $10.2M.
  • First Trust Direct Indexing first reported a position in Johnson & Johnson in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's Johnson & Johnson position peaked at $10.2M in Q3 2024.
  • 4,104 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.